AAAAAA
Results:
1-14
|
Results: 14
Authors:
Vuoristo, MS
Laine, S
Huhtala, H
Parvinen, LM
Hahka-Kemppinen, M
Korpela, M
Kumpulainen, E
Kellokumpu-Lehtinen, P
Citation: Ms. Vuoristo et al., Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma, EUR J CANC, 37(13), 2001, pp. 1629-1634
Authors:
Pertovaara, M
Korpela, M
Pasternack, A
Citation: M. Pertovaara et al., Factors predictive of renal involvement in patients with primary Sjogren'ssyndrome, CLIN NEPHR, 56(1), 2001, pp. 10-18
Authors:
Ainiala, H
Loukkola, J
Peltola, J
Korpela, M
Hietaharju, A
Citation: H. Ainiala et al., The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus, NEUROLOGY, 57(3), 2001, pp. 496-500
Authors:
Ainiala, H
Hietaharju, A
Loukkola, J
Peltola, J
Korpela, M
Metsanoja, R
Auvinen, A
Citation: H. Ainiala et al., Validity of the new American college of rheumatology criteria for neuropsychiatric lupus syndromes: A population-based evaluation, ARTH RH ART, 45(5), 2001, pp. 419-423
Authors:
Huusko, TM
Korpela, M
Karppi, P
Avikainen, V
Kautiainen, H
Sulkava, R
Citation: Tm. Huusko et al., Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland, ANN RHEUM D, 60(5), 2001, pp. 521-522
Authors:
Kurittu, J
Karp, M
Korpela, M
Citation: J. Kurittu et al., Detection of tetracyclines with luminescent bacterial strains, LUMINESCENC, 15(5), 2000, pp. 291-297
Authors:
Vuoristo, MS
Kellokumpu-Lehtinen, P
Laine, S
Parvinen, LM
Hahka-Kemppinen, M
Korpela, M
Kumpulainen, E
Citation: Ms. Vuoristo et al., The value of serum S-100 beta and interleukins as tumour markers in advanced melanoma, MELANOMA RE, 10(3), 2000, pp. 237-241
Authors:
Vuoristo, MS
Kellokumpu-Lehtinen, P
Parvinen, LM
Hahka-Kemppinen, M
Korpela, M
Kumpulainen, E
Laine, S
Citation: Ms. Vuoristo et al., Serum matrix metalloproteinase-2 as a prognostic marker in advanced cutaneous melanoma, ACTA ONCOL, 39(7), 2000, pp. 877-879
Authors:
Jaalinoja, J
Herva, R
Korpela, M
Hoyhtya, M
Turpeenniemi-Hujanen, T
Citation: J. Jaalinoja et al., Matrix metalloproteinase 2 (MMP-2) immunoreactive protein is associated with poor grade and survival in brain neoplasms, J NEURO-ONC, 46(1), 2000, pp. 81-90
Authors:
Yli-Kerttula, T
Luukkainen, R
Yli-Kerttula, U
Mottonen, T
Hakola, M
Korpela, M
Sanila, M
Parviainen, J
Uksila, J
Vainionpaa, R
Toivanen, A
Citation: T. Yli-kerttula et al., Effect of a three month course of ciprofloxacin on the outcome of reactivearthritis, ANN RHEUM D, 59(7), 2000, pp. 565-570
Authors:
Pertovaara, M
Korpela, M
Kouri, T
Pasternack, A
Citation: M. Pertovaara et al., The occurrence of renal involvement in primary Sjogren's syndrome: a studyof 78 patients, RHEUMATOLOG, 38(11), 1999, pp. 1113-1120
Authors:
Mottonen, T
Hannonen, P
Leirisalo-Repo, M
Nissila, M
Kautiainen, H
Korpela, M
Laasonen, L
Julkunen, H
Luukkainen, R
Vuori, K
Paimela, L
Blafield, H
Hakala, M
Ilva, K
Yli-Kerttula, U
Puolakka, K
Jarvinen, P
Hakola, M
Piirainen, H
Ahonen, J
Palvimaki, I
Forsberg, S
Koota, K
Friman, C
Citation: T. Mottonen et al., Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial, LANCET, 353(9164), 1999, pp. 1568-1573
Authors:
Pertovaara, M
Korpela, M
Uusitalo, H
Pukander, J
Miettinen, A
Helin, H
Pasternack, A
Citation: M. Pertovaara et al., Clinical follow up study of 87 patients with sicca symptoms (dryness of eyes or mouth, or both), ANN RHEUM D, 58(7), 1999, pp. 423-427
Authors:
Iltanen, S
Collin, P
Korpela, M
Holm, K
Partanen, J
Polvi, A
Maki, M
Citation: S. Iltanen et al., Celiac disease and markers of celiac disease latency in patients with primary Sjogren's syndrome, AM J GASTRO, 94(4), 1999, pp. 1042-1046
Risultati:
1-14
|